Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy

Clinical trial NCT07212335 · RECRUITING

Trial details

NCT number: NCT07212335
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Immune Effector Cell Associated Hematotoxicity

Start date: 2025-10-01
Primary completion: 2027-09-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.